Arvinas Statistics
NASDAQ: ARVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.38-0.07 (-0.94%)
Market open · Delayed 15 min · as of Oct 8, 1:21 PM ET
Arvinas by the numbers
Arvinas has a market capitalization of $476.2 million based on 64.52M shares outstanding. Its trailing P/E ratio is 28.4. The stock trades 13.9% below its 50-day average and 26.7% below its 200-day average.
Average daily trading volume is 779.46K shares, or about $5.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARVN valuation vs. peer median
| Metric | ARVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $476.17M | $470.37M | +1% |
| Avg. volume | 779.46K | 1.24M | -37% |
Peer median across 8 companies: CTNM, CAPR, ASMB, OVID, ALT, DRUG, EOLS, SPRY.
Valuation
- Market cap
- $476.17M
- P/E (TTM)
- 28.38
- EPS (TTM)
- $0.26
- Shares outstanding
- 64.52M
Price and trading
- Previous close
- 7.45
- Open
- 7.36
- Day range
- 7.25 – 7.45
- 52-week range
- 6.97 – 14.51
- 52-week change
- -19.89%
- Beta
- —
- Volume
- 275.43K
- Average volume
- 779.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 476.17M
- Pe
- 28.38
- Forward Pe
- -2.28
- Eps
- 0.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.51
- Week52 Low
- 6.97
- Avg Volume
- 779.46K
- Shares Outstanding
- 64.52M
- Ma50
- 8.57
- Ma200
- 10.07
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -49.14%
- Pct From52w Low
- 5.88%